SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001193125-16-559153
Filing Date
2016-04-27
Accepted
2016-04-27 15:24:34
Documents
7
Period of Report
2016-06-09
Effectiveness Date
2016-04-27

Document Format Files

Seq Description Document Type Size
1 DEF 14A d150771ddef14a.htm DEF 14A 553155
2 GRAPHIC g150771dsp049.jpg GRAPHIC 1894
3 GRAPHIC g150771dsp050.jpg GRAPHIC 1927
4 GRAPHIC g150771g17v71.jpg GRAPHIC 18671
5 GRAPHIC g150771g29h98.jpg GRAPHIC 22894
6 GRAPHIC g150771g55t53.jpg GRAPHIC 78324
7 GRAPHIC g150771g82u19.jpg GRAPHIC 80528
  Complete submission text file 0001193125-16-559153.txt   836403
Mailing Address 5500 FLATIRON PARKWAY SUITE 100 BOULDER CO 80301
Business Address 5500 FLATIRON PARKWAY SUITE 100 BOULDER CO 80301 (303) 625-5000
Clovis Oncology, Inc. (Filer) CIK: 0001466301 (see all company filings)

IRS No.: 900475355 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-35347 | Film No.: 161594984
SIC: 2834 Pharmaceutical Preparations